Related Articles
Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway
Curcumin increases the sensitivity of K562/DOX cells to doxorubicin by targeting S100 calcium‑binding protein A8 and P‑glycoprotein
The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance
Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1 Corrigendum in /10.3892/ijmm.2023.5315
Specific reversal of MDR1/P-gp-dependent multidrug resistance by RNA interference in colon cancer cells